Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP2 | P42575 | 1/20 | 0.74 |
| ▸ | NAAA | Q02083 | 1/20 | 0.69 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.68 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.61 |
| ▸ | FAAH | O00519 | 5/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.58 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.57 |
| ▸ | CNR1 | P21554 | 2/20 | 0.57 |
| ▸ | CNR2 | P34972 | 2/20 | 0.57 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.56 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.56 |
| ▸ | TSHR | P16473 | 1/20 | 0.56 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.56 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.56 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.56 |
| ▸ | PPARG | P37231 | 1/20 | 0.56 |
| ▸ | PPARD | Q03181 | 1/20 | 0.56 |
| ▸ | PPARA | Q07869 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8337296 | 1.00 | CASP2 (0.74) | CASP2NAAAEPHX2PLA2G2AFAAH | |
| SCHEMBL10420519 | 1.00 | CASP2 (0.74) | CASP2NAAAEPHX2PLA2G2AFAAH | |
| SCHEMBL8356691 | 1.00 | CASP2 (0.74) | CASP2NAAAEPHX2PLA2G2AFAAH | |
| SCHEMBL93996 | 1.00 | CASP2 (0.74) | CASP2NAAAEPHX2PLA2G2AFAAH | |
| SCHEMBL1001785 | 1.00 | CASP2 (0.74) | CASP2NAAAEPHX2PLA2G2AFAAH | |
| SCHEMBL10422182 | 1.00 | CASP2 (0.74) | CASP2NAAAEPHX2PLA2G2AFAAH | |
| SCHEMBL10686810 | 1.00 | CASP2 (0.74) | CASP2NAAAEPHX2PLA2G2AFAAH | |
| SCHEMBL10767322 | 1.00 | CASP2 (0.74) | CASP2NAAAEPHX2PLA2G2AFAAH | |
| SCHEMBL30678823 | 0.98 | CASP2 (0.71) | CASP2NAAAEPHX2PLA2G2AFAAH | |
| SCHEMBL30835571 | 0.98 | CASP2 (0.71) | CASP2NAAAEPHX2PLA2G2AFAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-4650988-B2 | — | — | 2011-03-16 | — | — | JP | claimed |
| EP-1226113-B1 | ESTERS COMPRISING A SECONDARY CARBAMOYL FUNCTION AND THEIR USE AS ODORANT ALCOHOL PRECURSORS | FIRMENICH & CIE (CH) | 2005-11-09 | — | — | EP | claimed |
| US-6677297-B2 | PERFUMES FOR TEXTILES; PROLONGED DIFFUSION | FIRMENICH SA (CH) | 2004-01-13 | — | — | US | claimed |
| JP-2003520203-A | — | — | 2003-07-02 | — | — | JP | claimed |
| US-20020144360-A1 | Esters comprising a secondary carbamoyl function and their use as odorant alcohol precursors | FIRMENICH SA (CH) | 2002-10-10 | — | — | US | claimed |
| EP-1226113-A1 | ESTERS COMPRISING A SECONDARY CARBAMOYL FUNCTION AND THEIR USE AS ODORANT ALCOHOL PRECURSORS | Firmenich S.A. (CH) | 2002-07-31 | — | — | EP | claimed |
| WO-2001028980-A1 | ESTERS COMPRISING A SECONDARY CARBAMOYL FUNCTION AND THEIR USE AS ODORANT ALCOHOL PRECURSORS | FIRMENICH S.A. (CH) | 2001-04-26 | — | — | WO | claimed |
| CN-121045053-A | Method for synthesizing N-octyl pyrrolidone by taking succinic anhydride as raw material | 新迈奇材料股份有限公司 | 2025-12-02 | — | — | CN | disclosed |
| CN-115701464-A | Super-hydrophobic finishing agent and preparation method and application thereof | 江苏金太阳纺织科技股份有限公司 | 2023-02-10 | — | — | CN | disclosed |
| CN-113385104-B | Preparation method of multifunctional surfactant resistant to hard water, acid and alkali and degradable | 青岛恒信达化工有限公司（CN） | 2023-01-13 | — | — | CN | disclosed |
| CN-115418148-A | Organic reversible thermochromic exterior wall coating and preparation method thereof | 中机铸材科技（福建）有限公司 | 2022-12-02 | — | — | CN | disclosed |
| WO-2021142577-A1 | ARYLAMIDE COMPOUND BASED ON BENZENE RING SUPRAMOLECULAR INTERACTION, SELF-ASSEMBLY MORPHOLOGY, AND USE | 易天奇 | 2021-07-22 | — | — | WO | disclosed |
| US-20180344859-A1 | NOVEL BIOMATERIALS AND A METHOD FOR MAKING AND USING SAME | ALUMEND, LLC (US) | 2018-12-06 | — | — | US | disclosed |
| EP-0473229-B1 | Bleaching and detergent compositions | UNILEVER NV (NL) | 1995-11-15 | — | — | EP | disclosed |
| EP-0473229-A1 | Bleaching and detergent compositions | UNILEVER N.V. (NL) | 1992-03-04 | — | — | EP | disclosed |
| US-4921942-A | Organometallic compounds | STEPAN COMPANY (US) | 1990-05-01 | — | — | US | disclosed |
| US-4724174-A | AMIDO CARBOXYL SOAPS; FILM-FORMING; SUBSTANTIVITY | STEPAN COMPANY (US) | 1988-02-09 | — | — | US | disclosed |
| US-4675422-A | ALUMINUM COATINGS | STEPAN COMPANY (US) | 1987-06-23 | — | — | US | disclosed |
| EP-0220934-A2 | Aluminium carboxylates | STEPAN COMPANY (US) | 1987-05-06 | — | — | EP | disclosed |
| US-4425161-A | Thermochromic materials | PILOT INK COMPANY, LTD., (JP) | 1984-01-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180344859-A1 | NOVEL BIOMATERIALS AND A METHOD FOR MAKING AND USING SAME | MMP1, PLOD3, MMP2 | CASP2 3112/4885NAAA 388/4885EPHX2 428/4885 |
| US-20020144360-A1 | Esters comprising a secondary carbamoyl function and their use as odorant alcohol precursors | ADH1C, ADH1A, CBR1 | CASP2 722/4885NAAA 2383/4885EPHX2 1283/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.